Prof. Seong Soo Joo, Gangneung-Wonju National University, South Korea
Dr. Joo Seong Soo (PhD) is a distinguished Professor at Gangneung-Wonju National University (GWNU) and CEO of HUSCION, specializing in medical microbiology, natural chemistry, and immunopharmacology π§¬π¬. With a career spanning academia and the pharmaceutical industry, he has led pioneering research in drug discovery, focusing on Alzheimerβs disease and other challenging illnesses ππ§ . Dr. Joo has developed over 1,000 lead compounds and holds 100+ patents π. His expertise in molecular cell biology, immunology, and pharmacology has earned him prestigious awards, including the Ministry of Health and Welfare Research Excellence Award π.
Professoinal Profile:
Scopus
Suitability for Best Researcher Award
Dr. Joo Seong Soo is a highly suitable candidate for the Best Researcher Award due to his exceptional contributions to drug discovery, medical microbiology, and immunopharmacology. His work in Alzheimerβs research, immunotherapy, and pharmaceutical innovations has had a profound impact on both academia and the pharmaceutical industry. His ability to bridge research and commercial drug development strengthens his candidacy
Education & Experience ππΌ
π Education:
-
Ph.D. in Immunology & Pharmacology β Chung-Ang University, Korea (2003) π
-
M.Sc. in Medical Microbiology β Long Island University, USA (1992) π₯
π Academic Experience:
-
Professor, GWNU (2010βPresent) π
-
Research Professor, Chungbuk National University (2007β2010) π¬
-
Research Professor, Chung-Ang University (2004β2007) ποΈ
π Industry Experience:
-
CEO, HUSCION (2018βPresent) π’
-
New Drug Development Manager, HanDok Pharma (2000β2002) π
-
Clinical Trial Manager, GSK Korea (1998β2000) π
-
New Drug Clinical Team Manager, JW Pharma (1993β1998) π₯
Professional Development π
Dr. Joo Seong Soo has played a transformative role in pharmaceutical R&D, blending academic expertise with industry leadership π¬π‘. As the founder and CEO of HUSCION, he has driven cutting-edge drug discovery, with a focus on molecular biology, immunology, and pharmacology π§¬. His work has led to the development of innovative therapeutics, particularly in treating neurodegenerative diseases like Alzheimerβs π§ . In addition to research, he has been a dedicated educator, mentoring students and fostering collaborative projects between academia and industry ππ€. His global experience in clinical trials and drug development has positioned him as a leading expert in life sciences π.
Research Focus π¬π§ͺ
Dr. Joo’s research encompasses medical microbiology, natural chemistry, and immunopharmacology, with an emphasis on drug discovery and molecular therapeutics π. His expertise in molecular cell biology, gene mutation analysis, and therapeutic cell manipulation has led to groundbreaking advancements in pharmaceuticals π§¬. A core focus of his work is on developing novel treatments for Alzheimerβs disease, utilizing bioactive compounds and immunomodulatory approaches π§ . Additionally, he explores antimicrobial resistance, inflammatory diseases, and targeted drug delivery systems π¦ . His extensive publication record and 100+ patents underscore his impact on global health and medicine ππ₯.
Awards & Honors ππ
-
Marquis Who’s Who in the World π
-
Marquis Whoβs Who in Medicine and Healthcare π₯
-
Outstanding Researcher Award, Gangneung-Wonju National University π
-
Ministry of Health and Welfare Research Excellence Award π
-
Star Laboratory Award, GWNU β
-
Associate Editor, Journal of Biomedical Research π
-
Meber, Society of Molecular and Cellular Biology, Institute of Food Technologists π§ͺ
Publication Top Notes:
π “Serotonin Influences Insulin Secretion in Rat Insulinoma INS β π Cited by: 1
π “Improvement of Cognitive Function by Fermented Panax ginseng C.A. Meyer Berries Extracts in an AF64A-Induced Memory Deficit Model” β π Cited by: 3
π “Effectiveness of Combinational Treatments for Alzheimerβs Disease with Human Neural Stem Cells and Microglial Cells Over-Expressing Functional Genes”β π Cited by: 4
π “Melatonin Can Modulate Neurodegenerative Diseases by Regulating Endoplasmic Reticulum Stress” β π Cited by: 20